Clinical trial
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
NCT00435461 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00435461 |
|---|---|
| Title | Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine |
| Official title | A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Drug |
| Interventions | Fluticasone furoate and fexofenadine |
| Enrollment | 1,000 |
| Start date | Dec 20, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 28, 2007 |
| First posted | Feb 15, 2007 |
| Last update posted | Mar 7, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: